Development and Evaluation of Vero Cell-Derived Master Donor Viruses for Influenza Pandemic Preparedness
The embryonated egg-based platform currently produces the majority of seasonal influenza vaccines by employing a well-developed master donor virus (MDV, A/PR/8/34 (PR8)) to generate high-growth reassortants (HGRs) for A/H1N1 and A/H3N2 subtypes. Although the egg-based platform can supply enough seas...
Autors principals: | Po-Ling Chen, Tsai-Teng Tzeng, Alan Yung-Chih Hu, Lily Hui-Ching Wang, Min-Shi Lee |
---|---|
Format: | Article |
Idioma: | English |
Publicat: |
MDPI AG
2020-10-01
|
Col·lecció: | Vaccines |
Matèries: | |
Accés en línia: | https://www.mdpi.com/2076-393X/8/4/626 |
Ítems similars
-
Influenza pandemic preparedness: gains made and the challenges remaining
per: Saurabh Shrivastava, et al.
Publicat: (2019-12-01) -
Preparedness for influenza vaccination during a pandemic in the World Health Organization Western Pacific Region
per: Leila Bell, et al.
Publicat: (2019-11-01) -
1918 Influenza Outcomes among Institutionalized Norwegian Populations: Implications for Disability-Inclusive Pandemic Preparedness
per: Jessica Dimka, et al.
Publicat: (2020-07-01) -
Incorporating Research and Evaluation into Pandemic Influenza Vaccination Preparedness and Response
per: Tom T. Shimabukuro, et al.
Publicat: (2014-04-01) -
Reassortment of high-yield influenza viruses in vero cells and safety assessment as candidate vaccine strains
per: Jian Zhou, et al.
Publicat: (2017-01-01)